These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1815971)

  • 1. Absolute bioavailability of nicotine applied to different nasal regions.
    Johansson CJ; Olsson P; Bende M; Carlsson T; Gunnarsson PO
    Eur J Clin Pharmacol; 1991; 41(6):585-8. PubMed ID: 1815971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arteriovenous differences in plasma concentration of nicotine and catecholamines and related cardiovascular effects after smoking, nicotine nasal spray, and intravenous nicotine.
    Gourlay SG; Benowitz NL
    Clin Pharmacol Ther; 1997 Oct; 62(4):453-63. PubMed ID: 9357397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative bioavailability of nicotine from a nasal spray in infectious rhinitis and after use of a topical decongestant.
    Lunell E; Molander L; Andersson M
    Eur J Clin Pharmacol; 1995; 48(1):71-5. PubMed ID: 7542589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of blood sampling site and physicochemical characteristics of drugs on bioavailability after nasal administration in the sheep model.
    Illum L; Hinchcliffe M; Davis SS
    Pharm Res; 2003 Sep; 20(9):1474-84. PubMed ID: 14567644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absolute bioavailability of intranasal fluticasone furoate in healthy subjects.
    Allen A; Down G; Newland A; Reynard K; Rousell V; Salmon E; Scott R
    Clin Ther; 2007 Jul; 29(7):1415-20. PubMed ID: 17825692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo evaluation of nicotine lyophilised nasal insert in sheep.
    McInnes FJ; Thapa P; Baillie AJ; Welling PG; Watson DG; Gibson I; Nolan A; Stevens HN
    Int J Pharm; 2005 Nov; 304(1-2):72-82. PubMed ID: 16183221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioavailability and absorption kinetics of nicotine following application of a transdermal system.
    Gupta SK; Benowitz NL; Jacob P; Rolf CN; Gorsline J
    Br J Clin Pharmacol; 1993 Sep; 36(3):221-7. PubMed ID: 9114908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arterial/venous plasma nicotine concentrations following nicotine nasal spray.
    Guthrie SK; Zubieta JK; Ohl L; Ni L; Koeppe RA; Minoshima S; Domino EF
    Eur J Clin Pharmacol; 1999 Nov; 55(9):639-43. PubMed ID: 10638392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A dose-ranging pharmacokinetic study of nicotine tartrate following single-dose delayed-release oral and intravenous administration.
    Compton RF; Sandborn WJ; Lawson GM; Sheets AJ; Mays DC; Zins BJ; Tremaine WJ; Lipsky JJ; Mahoney DW; Zinsmeister AR; Offord KP; Hurt RD; Evans BK; Green J
    Aliment Pharmacol Ther; 1997 Oct; 11(5):865-74. PubMed ID: 9354194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose released and absolute bioavailability of nicotine from a nicotine vapor inhaler.
    Molander L; Lunell E; Andersson SB; Kuylenstierna F
    Clin Pharmacol Ther; 1996 Apr; 59(4):394-400. PubMed ID: 8612383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotine Population Pharmacokinetics in Healthy Adult Smokers: A Retrospective Analysis.
    Marchand M; Brossard P; Merdjan H; Lama N; Weitkunat R; Lüdicke F
    Eur J Drug Metab Pharmacokinet; 2017 Dec; 42(6):943-954. PubMed ID: 28283988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stable isotope method for studying transdermal drug absorption: the nicotine patch.
    Benowitz NL; Chan K; Denaro CP; Jacob P
    Clin Pharmacol Ther; 1991 Sep; 50(3):286-93. PubMed ID: 1914363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stable isotope studies of nicotine kinetics and bioavailability.
    Benowitz NL; Jacob P; Denaro C; Jenkins R
    Clin Pharmacol Ther; 1991 Mar; 49(3):270-7. PubMed ID: 2007322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and pharmacodynamic effects of nicotine nasal spray devices on cardiovascular and pulmonary function.
    Fishbein L; O'Brien P; Hutson A; Theriaque D; Stacpoole PW; Flotte T
    J Investig Med; 2000 Nov; 48(6):435-40. PubMed ID: 11094866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 2nd communication: drops with ethanol.
    Lintz W; Barth H; Becker R; Frankus E; Schmidt-Böthelt E
    Arzneimittelforschung; 1998 May; 48(5):436-45. PubMed ID: 9638309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotine administration in rabbits using Habitrol nicotine patches and nicotine nasal spray.
    Sipe RV; Buck DC; Hollinger JO
    Clin Exp Pharmacol Physiol; 2000 Jul; 27(7):480-2. PubMed ID: 10874502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioavailability of leuprolide acetate following nasal and inhalation delivery to rats and healthy humans.
    Adjei A; Sundberg D; Miller J; Chun A
    Pharm Res; 1992 Feb; 9(2):244-9. PubMed ID: 1553349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 3rd Communication: suppositories.
    Lintz W; Barth H; Osterloh G; Schmidt-Böthelt E
    Arzneimittelforschung; 1998 Sep; 48(9):889-99. PubMed ID: 9793614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-dose pharmacokinetics of nicotine when given with a novel mouth spray for nicotine replacement therapy.
    Kraiczi H; Hansson A; Perfekt R
    Nicotine Tob Res; 2011 Dec; 13(12):1176-82. PubMed ID: 21849415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomised, crossover study on an electronic vapour product, a nicotine inhalator and a conventional cigarette. Part A: Pharmacokinetics.
    Walele T; Sharma G; Savioz R; Martin C; Williams J
    Regul Toxicol Pharmacol; 2016 Feb; 74():187-92. PubMed ID: 26696273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.